You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》據報騰訊(00700.HK)參投微醫集團籌未來數月港IPO 募7億至8億美元
阿思達克 06-04 17:03
據《南華早報》引述消息稱,騰訊(00700.HK)參與投資的線上醫療診斷服務商微醫集團(WeDoctor)尋求未來數月在香港上市,集資7億至8億美元,並已僱用招商銀行、花旗及摩通協助吸引投資者。

微醫2018年曾集資5億美元,當時與2,700間醫院、22萬位醫生、1.5萬間藥房合作,月度活躍用戶達2,700萬戶,估值55億美元。

根據該應用程序,屆今年5月15日,已登記醫生增至約24萬名。除線上診斷外,微醫其他業務包括雲服務、保險及醫藥。

受惠新冠疫情致遙距醫療需求激增,今年以來上市同業平安好醫生(01833.HK)股價累升約86.6%。此外,阿里健康(00241.HK)更升逾1.1倍,另美國線上診斷同業Teladoc Health年初以來亦累升約一倍。

華興資本料平安好醫生將於2022年或之前達至收支平衡,據熟悉微醫財務人士稱,微醫亦能夠在大約相同的時間扭虧轉盈。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account